OHSU

IRB #

IRB00008373

Title

A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma Patients to Assess the Relationship between Patient Outcomes, Treatment Regimens and Molecular Profiles

Principal Investigator

Emma Scott

Study Purpose

This research is being done because we hope that a better understanding of multiple myeloma will allow for more effective drugs with fewer side effects for patients with multiple myeloma. The purpose of this study is to collect, store, catalog and analyze blood samples, bone marrow samples and related health information from newly diagnosed multiple myeloma patients.

Medical Condition(s)

Multiple Myeloma

Eligibility Criteria

Subjects should be 18 years or older.
Subjects should have a diagnosis of symptomatic multiple myeloma.
Subjects should not already be receiving systemic therapy for multiple myeloma.
Subjects should not be enrolled in a blinded clinical trial for treatment of multiple myeloma.

Age Range

18 - 99

Healthy Volunteers Needed

No

Duration of Participation

5 years

Minors Included

No

Contact

Clinical Trials Information Line: Phone 503-494-1080 or trials@ohsu.edu

Sponsor

MMRF (Multiple Myeloma Research Foundation)

Recruitment End

10/01/2014

Compensation Provided

No


Go Back